ORIC (STOCKS)
Oric Pharmaceuticals, Inc. Common Stock
$8.380000
+0.110000 (+1.33%)
Prev close: $8.270000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jacob M. Chacko
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $869.55M
- Employees
- 128
- P/E (TTM)
- -5.87
- P/B (TTM)
- 2.06
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $14.69M |
| Operating Expenses | $149.91M |
| Operating Income/Loss | -$149.91M |
| Income/Loss From Continuing Operations After Tax | -$135.21M |
| Income/Loss From Continuing Operations Before Tax | -$135.21M |
| Net Income/Loss | -$135.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$135.21M |
| Net Income/Loss Available To Common Stockholders, Basic | -$135.21M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.41 |
| Diluted Earnings Per Share | -$1.41 |
| Basic Average Shares | 287,537,186 |
| Diluted Average Shares | 287,537,186 |
| Assets | $436.76M |
| Current Assets | $290.23M |
| Noncurrent Assets | $146.53M |
| Fixed Assets | $2.15M |
| Other Non-current Assets | $144.38M |
| Liabilities | $21.21M |
| Current Liabilities | $17.77M |
| Accounts Payable | $2.90M |
| Other Current Liabilities | $14.88M |
| Noncurrent Liabilities | $3.43M |
| Equity | $415.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $415.56M |
| Liabilities And Equity | $436.76M |
| Net Cash Flow From Operating Activities | -$110.88M |
| Net Cash Flow From Operating Activities, Continuing | -$110.88M |
| Net Cash Flow From Investing Activities | -$188.46M |
| Net Cash Flow From Investing Activities, Continuing | -$188.46M |
| Net Cash Flow From Financing Activities | $306.39M |
| Net Cash Flow From Financing Activities, Continuing | $306.39M |
| Net Cash Flow | $7.06M |
| Net Cash Flow, Continuing | $7.06M |
| Comprehensive Income/Loss | -$135.69M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$135.71M |
| Other Comprehensive Income/Loss | $98.49M |